Figure 3.
Proposed model of potential risk factors (> 50% of the study population) associated with osteonecrosis of the jaw among patients with no history of cancer receiving bisphosphonates for osteoporosis or Paget’s disease
Proposed model of potential risk factors (> 50% of the study population) associated with osteonecrosis of the jaw among patients with no history of cancer receiving bisphosphonates for osteoporosis or Paget’s disease